Conceptual Framework to Guide Early Diagnosis Programs for Symptomatic Cancer as Part of Global Cancer Control

dc.contributor.authorKoo, Monica Minjoung
dc.contributor.authorUnger-Saldaña, Karla
dc.contributor.authorMwaka, Amos Deogratius
dc.contributor.authorCorbex, Marilys
dc.contributor.authorGinsburg, Ophira
dc.contributor.authorWalter, M. Fiona
dc.contributor.authorCalanzani, Natalia
dc.contributor.authorMoodley, Jennifer
dc.contributor.authorRubin, P. Greg
dc.contributor.authorLyratzopoulos, Georgios
dc.date.accessioned2021-04-29T09:43:25Z
dc.date.available2021-04-29T09:43:25Z
dc.date.issued2021-01-06
dc.description.abstractDiagnosing cancer earlier can enable timely treatment and optimize outcomes. Worldwide, national cancer control plans increasingly encompass early diagnosis programs for symptomatic patients, commonly comprising awareness campaigns to encourage prompt help-seeking for possible cancer symptoms and health system policies to support prompt diagnostic assessment and access to treatment. By their nature, early diagnosis programs involve complex public health interventions aiming to address unmet health needs by acting on patient, clinical, and system factors. However, there is uncertainty regarding how to optimize the design and evaluation of such interventions. We propose that decisions about early diagnosis programs should consider four interrelated components: first, the conduct of a needs assessment (based on cancer-site–specific statistics) to identify the cancers that may benefit most from early diagnosis in the target population; second, the consideration of symptom epidemiology to inform prioritization within an intervention; third, the identification of factors influencing prompt help-seeking at individual and system level to support the design and evaluation of interventions; and finally, the evaluation of factors influencing the health systems’ capacity to promptly assess patients. This conceptual framework can be used by public health researchers and policy makers to identify the greatest evidence gaps and guide the design and evaluation of local early diagnosis programs as part of broader cancer control strategies.en_US
dc.identifier.citationKoo, M.M., Unger-Saldaña, K., Mwaka, A.D., Corbex, M., Ginsburg, O., Walter, F.M., Calanzani, N., Moodley, J., Rubin, G.P. and Lyratzopoulos, G., 2021. Conceptual Framework to Guide Early Diagnosis Programs for Symptomatic Cancer as Part of Global Cancer Control. JCO Global Oncology, 7, pp.35-45.en_US
dc.identifier.issn2687-8941
dc.identifier.urihttp://hdl.handle.net/20.500.12280/2791
dc.language.isoenen_US
dc.publisherWolters Kluwer Health, Inc.en_US
dc.relation.ispartofseriesJCO Global Oncology;7
dc.subjectConceptual frameworken_US
dc.subjectEarly diagnosisen_US
dc.subjectSymptomatic canceren_US
dc.subjectCancer controlen_US
dc.titleConceptual Framework to Guide Early Diagnosis Programs for Symptomatic Cancer as Part of Global Cancer Controlen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Mwaka_ARTICLE_MKPGS_2021_Conceptual.pdf
Size:
335.56 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: